GO:0005690 U4atac snRNP: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005690 defines the U4atac snRNP, a minor spliceosome ribonucleoprotein complex built on the U4atac snRNA plus a heptameric Sm ring and U4atac-specific proteins.
• The U4atac snRNP is essential for U12-type intron splicing, a parallel splicing system that removes a small subset of introns from human genes.
• Its protein composition closely mirrors the major U4/U6.U5 tri-snRNP, including hPrp31 and Sm proteins, but it pairs with U6atac rather than U6.
• Specific domains of U4atac snRNA are required for U12-dependent splicing in vivo, making the RNA a critical functional determinant.
• Mutations affecting U4atac snRNP function cause MOPD I (Taybi-Linder syndrome), a severe developmental disorder linked to defective minor spliceosome activity.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of U4atac snRNP components in disease and development.
Description
The U4atac snRNP (GO:0005690) is a cellular component of the minor spliceosome, a ribonucleoprotein machine that catalyzes the removal of U12-type introns from a small but essential subset of human pre-mRNAs. It is defined by the presence of the small nuclear RNA U4atac, a heptameric ring of Sm proteins, and several proteins unique to this snRNP that remain associated with U4atac snRNA whether it is free, assembled into the U4atac/U6atac complex, or incorporated into higher-order spliceosomal complexes. Because U12-type introns are rare but often reside in genes governing cell cycle, DNA repair and development, the U4atac snRNP punches above its weight in cellular physiology. Researchers study GO:0005690 to understand how a low-abundance splicing machine achieves high-fidelity intron recognition and to explain why its disruption produces tissue-specific and developmental phenotypes. Structural and biochemical work has revealed that the U4atac snRNP shares architectural logic with the major U4/U6.U5 tri-snRNP, yet uses distinct RNA-protein contacts to engage U12-type substrates. This makes it a tractable model for comparative spliceosome biology and for therapeutic target discovery in splicing-related disease. This article integrates the QuickGO definition with verified PubMed literature to summarize the composition, assembly, molecular mechanism, disease links and CRISPR-based research methods relevant to the U4atac snRNP.
U4atac snRNP At A Glance
| GO ID | GO:0005690 |
|---|---|
| GO term | U4atac snRNP |
| Ontology | cellular_component |
| Synonym | snRNP U4atac |
| Major function | Component of the minor spliceosome involved in U12-type intron splicing |
| Core RNA | U4atac small nuclear RNA |
| Core proteins | Heptameric Sm ring and U4atac-specific proteins including hPrp31 |
| Assembly states | Free U4atac snRNP, U4atac/U6atac complex, and higher-order spliceosomal complexes |
| Related complex | U4atac/U6atac.U5 tri-snRNP with protein composition similar to U4/U6.U5 |
What Is GO:0005690?
The U4atac snRNP is a ribonucleoprotein complex whose core contains the small nuclear RNA U4atac and a heptameric ring of Sm proteins, together with several proteins that are unique to this snRNP. These unique proteins largely remain bound to U4atac snRNA both when the snRNP is free and when it is assembled into the U4atac/U6atac complex or into a series of spliceosomal complexes. Functionally, it is a building block of the minor spliceosome that participates in U12-type intron splicing.
Why Is U4atac snRNP Important in Cell Biology?
The U4atac snRNP is important because it is the defining RNA-protein module of the minor spliceosome, the machinery responsible for removing U12-type introns from genes that are frequently involved in cell cycle control, DNA repair and development. Without functional U4atac snRNP, U12-type introns remain unspliced, which can trigger developmental defects and disease, as illustrated by MOPD I. Studying GO:0005690 therefore connects fundamental spliceosome architecture to human genetics and provides a target for mechanistic and therapeutic research.
• Defines the minor spliceosome branch that removes U12-type introns from a subset of human genes.
• Contains U4atac snRNA, whose domains are required for U12-dependent splicing in vivo.
• Shares protein composition with the major U4/U6.U5 tri-snRNP, enabling comparative spliceosome studies.
• Uses hPrp31 for dual U4 and U4atac snRNA binding, linking major and minor splicing regulation.
• Disruption of U4atac snRNP function is linked to MOPD I, a severe developmental disorder.
• LSM7-dependent snRNA modification pathways influence spliceosome fidelity and stem cell differentiation.
• Provides a model for understanding how low-abundance snRNPs achieve high-fidelity splicing.
• Offers CRISPR-tractable targets for dissecting RNA-protein interactions in splicing.
U4atac snRNP: Assembly, Structure and Molecular Mechanism
Assembly of the U4atac snRNP
In simple terms: The U4atac snRNP is built by loading Sm proteins onto U4atac RNA and adding specific helper proteins.
The U4atac snRNP contains U4atac snRNA, a heptameric Sm protein ring, and several U4atac-specific proteins that remain associated with the RNA in free and assembled states. Its protein composition is similar to that of the major U4/U6.U5 tri-snRNP, indicating a shared assembly logic between minor and major spliceosomes. The abundance of spliceosomal snRNPs, including U4atac, is not limiting for U12-type intron splicing, suggesting that assembly is regulated rather than simply driven by concentration.
U4atac snRNA domains and RNA requirements
In simple terms: Specific parts of the U4atac RNA are needed for it to work in splicing.
Domains of human U4atac snRNA are required for U12-dependent splicing in vivo, and mutations in these regions impair minor spliceosome function. RNA structural requirements govern the association of hPrp31 with U4 and U4atac snRNPs, showing that the RNA fold dictates protein recruitment. Structural analysis of hPrp31 revealed the basis for dual U4 and U4atac snRNA-binding specificity, linking RNA sequence and protein recognition.
Structure and composition of the U4atac/U6atac.U5 tri-snRNP
In simple terms: The U4atac snRNP joins U6atac and U5 to form a three-part machine.
Human U4/U6.U5 and U4atac/U6atac.U5 tri-snRNPs exhibit similar protein compositions, indicating that the minor tri-snRNP is built from a conserved protein toolkit. The fully assembled human minor spliceosome has been resolved structurally, revealing how U12-type introns are engaged by the U4atac-containing machinery. These structures show that the U4atac snRNP is not a static particle but a dynamic module that rearranges during spliceosome activation.
Molecular mechanism of U12-type intron splicing
In simple terms: The U4atac snRNP helps the minor spliceosome cut out rare introns.
The U4atac snRNP participates in the minor spliceosome pathway that removes U12-type introns, a class of introns distinct from the major U2-type introns. Biochemical defects in minor spliceosome function, including those affecting U4atac snRNP components, impair U12-type intron splicing and are linked to developmental disease. LSM7 coordinates scaRNA-mediated snRNA modification to ensure spliceosome fidelity, connecting RNA modification pathways to U4atac snRNP function.
Regulation by RNA modification and protein cofactors
In simple terms: Chemical marks on snRNA and helper proteins tune how well the U4atac snRNP works.
LSM7-dependent scaRNA-mediated snRNA modification is required for spliceosome fidelity and spermatogonial stem cell differentiation, implicating RNA modification in U4atac snRNP regulation. hPrp31 binding to U4atac snRNA depends on specific RNA structural features, providing a checkpoint for snRNP assembly. The similar protein composition of major and minor tri-snRNPs suggests that shared cofactors may regulate both pathways.
Key Genes Involved in GO:0005690 U4atac snRNP
The following genes and proteins are core components or regulators of the U4atac snRNP and its minor spliceosome pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| U4atac | Small nuclear RNA component of the U4atac snRNP | Domains required for U12-dependent splicing in vivo |
| PRPF31 | hPrp31 protein binds U4 and U4atac snRNA | Dual RNA-binding specificity and structural requirements |
| LSM7 | LSM protein involved in snRNA modification and spliceosome fidelity | Links scaRNA-mediated modification to U4atac snRNP function |
| SNRPB | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| SNRPD1 | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| SNRPD2 | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| SNRPD3 | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| SNRPE | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| SNRPF | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| SNRPG | Sm protein component of the heptameric ring | Core snRNP assembly and stability |
| U6atac | Partners with U4atac in the U4atac/U6atac complex | Minor tri-snRNP assembly and catalysis |
| U5 | Shared snRNA in major and minor tri-snRNPs | Tri-snRNP composition comparison |
| PRPF8 | Core tri-snRNP protein | Conserved protein composition of U4atac/U6atac.U5 |
| PRPF6 | Tri-snRNP protein | Conserved protein composition of U4atac/U6atac.U5 |
| PRPF4 | Tri-snRNP protein | Conserved protein composition of U4atac/U6atac.U5 |
| PRPF3 | Tri-snRNP protein | Conserved protein composition of U4atac/U6atac.U5 |
| RNU4ATAC | Gene encoding U4atac snRNA | Mutations linked to MOPD I |
How Is U4atac snRNP Regulated?
Regulation of the U4atac snRNP occurs at multiple levels. The abundance of spliceosomal snRNPs is not limiting for U12-type intron splicing, implying that activity is controlled by assembly, modification or recruitment rather than by raw concentration. LSM7 coordinates scaRNA-mediated snRNA modification to ensure spliceosome fidelity, providing a direct link between RNA modification and U4atac snRNP function. hPrp31 binding to U4atac snRNA depends on specific RNA structural requirements, adding a protein-level checkpoint for snRNP assembly. Together, these mechanisms tune minor spliceosome activity in development and disease.
U4atac snRNP and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNU4ATAC | MOPD I (Taybi-Linder syndrome) | Patient-derived fibroblasts or iPSCs with point mutations |
| LSM7 | Spliceosome fidelity and spermatogonial stem cell differentiation | Knockout mouse or cell model |
| PRPF31 | Retinal degeneration and splicing defects | Knock-in of patient mutations in retinal organoids |
| U4atac | U12-type intron splicing defects | RNA domain deletion or point mutants in HEK293 cells |
| SNRPB | SnRNP assembly and splicing fidelity | CRISPR knockout in cell lines |
MOPD I (Taybi-Linder syndrome) and minor spliceosome defects
Biochemical defects in minor spliceosome function, including impaired U4atac snRNP activity, are linked to the developmental disorder MOPD I. Mutations affecting U4atac snRNA or its associated machinery reduce U12-type intron splicing, which is thought to contribute to the severe growth and brain phenotypes of the disease.
Spliceosome fidelity and stem cell differentiation
LSM7-dependent scaRNA-mediated snRNA modification is required for spliceosome fidelity and spermatogonial stem cell differentiation, connecting U4atac snRNP-related pathways to stem cell biology. This suggests that minor spliceosome dysfunction may affect tissue-specific differentiation programs beyond classical developmental disorders.
Cancer and splicing dysregulation
Although direct evidence for U4atac snRNP mutations in cancer is limited in the provided literature, the minor spliceosome is part of the broader splicing machinery whose dysregulation is a hallmark of cancer. Research on U12-type intron splicing may therefore inform studies of splicing-targeted therapies.
From U4atac snRNP-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of U4atac snRNP loss on U12-type intron splicing? | CRISPR knockout of core Sm or U4atac-specific genes |
| How do disease mutations in U4atac snRNA affect splicing? | Point-mutation knock-in of patient variants |
| Where does hPrp31 bind U4atac snRNA? | Tagged knock-in of PRPF31 for crosslinking and imaging |
| Can overexpression rescue minor spliceosome defects? | Overexpression of wild-type or mutant U4atac snRNA |
| What proteins co-assemble with U4atac snRNP? | Affinity purification with tagged U4atac-specific proteins |
| How does LSM7 modification affect snRNP function? | Knockout and rescue with modification-deficient LSM7 |
How to Study the U4atac snRNP Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | U12-type intron retention and splicing efficiency | Assessing U4atac snRNP loss-of-function |
| Affinity purification-mass spectrometry | Protein composition of U4atac snRNP | Comparing minor and major tri-snRNPs |
| Cryo-EM | Three-dimensional structure of minor spliceosome | Mechanistic studies of U12-type intron engagement |
| CLIP or crosslinking | RNA-protein binding sites | Mapping hPrp31-U4atac interactions |
| RT-qPCR | Steady-state levels of U4atac snRNA | Validating knockout or knockdown |
| CRISPR knockout screening | Fitness effects of snRNP gene loss | Identifying essential U4atac snRNP components |
| RNA modification mapping | snRNA modification status | Linking LSM7 to spliceosome fidelity |
| Fluorescence microscopy | Subcellular localization of snRNP proteins | Tracking assembly and stress responses |
RNA-seq and intron retention analysis
RNA-seq can quantify U12-type intron retention as a readout of U4atac snRNP function, because loss of minor spliceosome activity leads to unspliced U12-type introns. Comparing wild-type and mutant cells reveals which genes depend on the U4atac snRNP.
Proteomics and affinity purification
Affinity purification coupled to mass spectrometry identifies proteins associated with U4atac snRNA and confirms the shared composition of U4atac/U6atac.U5 and U4/U6.U5 tri-snRNPs. This approach can detect disease-related changes in snRNP composition.
Structural biology and crosslinking
Cryo-EM and crosslinking methods have resolved how the fully assembled human minor spliceosome engages U12-type introns, providing mechanistic insight into U4atac snRNP rearrangements. Structural studies of hPrp31 have defined its dual U4 and U4atac RNA-binding mode.
Imaging and RNA modification mapping
Fluorescence imaging of tagged snRNP proteins can track U4atac snRNP localization, while modification mapping identifies scaRNA-mediated snRNA marks that require LSM7. These methods connect RNA modification to spliceosome fidelity.
How CRISPR Can Be Used to Study GO:0005690 U4atac snRNP
Knockout
CRISPR knockout of U4atac snRNP core components such as Sm proteins or U4atac-specific factors can reveal their requirement for U12-type intron splicing and cell viability. Knockout models are useful for identifying which genes depend on the minor spliceosome.
Point Mutation
Point mutations in U4atac snRNA domains or in PRPF31 can be introduced to mimic patient variants and test their effects on splicing and protein binding. These models help distinguish pathogenic from benign variants.
Knock-in
Knock-in of tagged U4atac-specific proteins enables affinity purification and imaging of the U4atac snRNP in its native context. Tagged knock-in also allows tracking of assembly states during spliceosome activation.
Overexpression
Overexpression of wild-type or mutant U4atac snRNA can test whether increasing snRNP levels rescues splicing defects, given that snRNP abundance is not normally limiting. This approach can also probe dominant-negative effects of disease mutations.
How EDITGENE Supports U4atac snRNP Research
Researchers studying U4atac snRNP-related genes often need to determine whether a candidate gene is causally involved in minor spliceosome function, U12-type intron splicing or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly in relevant cellular systems.
Contact EDITGENE today to design your custom CRISPR model for U4atac snRNP research.
Frequently Asked Questions About U4atac snRNP
What is the U4atac snRNP?
The U4atac snRNP is a ribonucleoprotein complex containing U4atac snRNA, a heptameric Sm ring and U4atac-specific proteins, and it functions in the minor spliceosome.
What is GO:0005690?
GO:0005690 is the Gene Ontology identifier for the U4atac snRNP cellular component.
What genes are involved in the U4atac snRNP?
Key genes include U4atac (RNU4ATAC), PRPF31, LSM7 and the Sm protein genes SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG.
What does the U4atac snRNP do?
It participates in the minor spliceosome to remove U12-type introns from a subset of human pre-mRNAs.
How is the U4atac snRNP different from the U4 snRNP?
The U4atac snRNP contains U4atac snRNA and functions in U12-type splicing, while the U4 snRNP contains U4 snRNA and functions in U2-type splicing; their protein compositions are similar.
What diseases are linked to U4atac snRNP dysfunction?
MOPD I (Taybi-Linder syndrome) is linked to biochemical defects in minor spliceosome function involving U4atac snRNP components.
How can I study U4atac snRNP function?
CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression and RNA-seq-based intron retention assays are common approaches.
Is U4atac snRNP abundance limiting for splicing?
No, studies indicate that the abundance of spliceosomal snRNPs is not limiting for U12-type intron splicing.
What proteins bind U4atac snRNA?
hPrp31 binds U4atac snRNA with structural specificity, and Sm proteins form the core ring of the snRNP.
Can CRISPR be used to model U4atac snRNP disease mutations?
Yes, CRISPR point-mutation knock-in can recreate patient variants in U4atac snRNA or associated genes to study splicing defects.
Conclusion
The U4atac snRNP (GO:0005690) is a specialized ribonucleoprotein complex that defines the minor spliceosome branch responsible for U12-type intron removal. Its composition, assembly and RNA-protein interactions are increasingly well understood through structural and biochemical studies. Because dysfunction of this complex is linked to severe developmental disease such as MOPD I, it remains an important target for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with RNA-seq and proteomics, provide a powerful toolkit for dissecting U4atac snRNP biology and its role in human disease.
References
- 1. Bai R et al.. 2024. Structural basis of U12-type intron engagement by the fully assembled human minor spliceosome.. Science 383(6688):1245-1252 PMID: 38484052
- 2. Schneider C et al.. 2002. Human U4/U6.U5 and U4atac/U6atac.U5 tri-snRNPs exhibit similar protein compositions.. Mol Cell Biol 22(10):3219-29 PMID: 11971955
- 3. Pessa HK et al.. 2006. The abundance of the spliceosomal snRNPs is not limiting the splicing of U12-type introns.. RNA 12(10):1883-92 PMID: 16957280
- 4. Shukla GC et al.. 2002. Domains of human U4atac snRNA required for U12-dependent splicing in vivo.. Nucleic Acids Res 30(21):4650-7 PMID: 12409455
- 5. Qi H et al.. 2026. LSM7 coordinates scaRNA-mediated snRNA modification to ensure spliceosome fidelity and spermatogonial stem cell differentiation.. Cell Death Differ PMID: 42168358
- 6. Liu S et al.. 2011. Structural basis for the dual U4 and U4atac snRNA-binding specificity of spliceosomal protein hPrp31.. RNA 17(9):1655-63 PMID: 21784869
- 7. Schultz A et al.. 2006. RNA structural requirements for the association of the spliceosomal hPrp31 protein with the U4 and U4atac small nuclear ribonucleoproteins.. J Biol Chem 281(38):28278-86 PMID: 16857676
- 8. Jafarifar F et al.. 2014. Biochemical defects in minor spliceosome function in the developmental disorder MOPD I.. RNA 20(7):1078-89 PMID: 24865609
